Chartwell Investment Partners’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-7,086
| Closed | -$691K | – | 426 |
|
2022
Q2 | $691K | Buy |
7,086
+106
| +2% | +$10.3K | 0.03% | 379 |
|
2022
Q1 | $654K | Buy |
6,980
+408
| +6% | +$38.2K | 0.02% | 396 |
|
2021
Q4 | $560K | Hold |
6,572
| – | – | 0.02% | 406 |
|
2021
Q3 | $630K | Sell |
6,572
-15,271
| -70% | -$1.46M | 0.02% | 403 |
|
2021
Q2 | $2.13M | Sell |
21,843
-14
| -0.1% | -$1.36K | 0.06% | 287 |
|
2021
Q1 | $2.13M | Sell |
21,857
-2,175
| -9% | -$211K | 0.06% | 276 |
|
2020
Q4 | $2.3M | Buy |
24,032
+214
| +0.9% | +$20.5K | 0.07% | 266 |
|
2020
Q3 | $2.29M | Buy |
23,818
+4,918
| +26% | +$473K | 0.08% | 255 |
|
2020
Q2 | $2.31M | Buy |
18,900
+12,782
| +209% | +$1.56M | 0.09% | 254 |
|
2020
Q1 | $530K | Sell |
6,118
-300
| -5% | -$26K | 0.02% | 364 |
|
2019
Q4 | $690K | Hold |
6,418
| – | – | 0.02% | 374 |
|
2019
Q3 | $578K | Sell |
6,418
-182
| -3% | -$16.4K | 0.02% | 386 |
|
2019
Q2 | $557K | Sell |
6,600
-1,507
| -19% | -$127K | 0.02% | 394 |
|
2019
Q1 | $714K | Buy |
8,107
+413
| +5% | +$36.4K | 0.02% | 400 |
|
2018
Q4 | $549K | Sell |
7,694
-362
| -4% | -$25.8K | 0.02% | 424 |
|
2018
Q3 | $990K | Sell |
8,056
-33,122
| -80% | -$4.07M | 0.03% | 442 |
|
2018
Q2 | $4.05M | Sell |
41,178
-20,081
| -33% | -$1.97M | 0.12% | 230 |
|
2018
Q1 | $5.08M | Sell |
61,259
-1,023
| -2% | -$84.8K | 0.17% | 184 |
|
2017
Q4 | $4.83M | Sell |
62,282
-11,146
| -15% | -$865K | 0.16% | 203 |
|
2017
Q3 | $4.5M | Buy |
73,428
+3,532
| +5% | +$216K | 0.15% | 204 |
|
2017
Q2 | $3.22M | Buy |
69,896
+3,992
| +6% | +$184K | 0.12% | 231 |
|
2017
Q1 | $2.85M | Sell |
65,904
-80,108
| -55% | -$3.47M | 0.1% | 240 |
|
2016
Q4 | $5.65M | Buy |
146,012
+24,057
| +20% | +$931K | 0.19% | 170 |
|
2016
Q3 | $6.18M | Buy |
+121,955
| New | +$6.18M | 0.11% | 225 |
|